Xuan-Yu Li
Overview
Explore the profile of Xuan-Yu Li including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
64
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li X, Yuan L, Ding C, Guo T, Du W, Jiang J, et al.
J Alzheimers Dis
. 2024 Aug;
101(2):589-601.
PMID: 39213059
Background: A range of imaging modalities have reported Alzheimer's disease-related abnormalities in individuals experiencing subjective cognitive decline (SCD). However, there has been no consistent local abnormality identified across multiple neuroimaging...
2.
Li X, Qi Y, Li P, Xue J, Li X, Muhammad I, et al.
Front Microbiol
. 2023 Aug;
14:1191837.
PMID: 37577435
Multidrug-resistant () often cause intestinal infections in cats. The aim of this study was to investigate a multidrug-resistant isolate for plasmidic and chromosomal antimicrobial resistance and their genetic environment. strain...
3.
Li X, Xue J, Qi Y, Muhammad I, Wang H, Li X, et al.
Int J Mol Sci
. 2023 May;
24(10).
PMID: 37240435
Antibiotic tolerance has become an increasingly serious crisis that has seriously threatened global public health. However, little is known about the exogenous factors that can trigger the development of antibiotic...
4.
Li X, Qi Y, Xue J, Xu G, Xu Y, Li X, et al.
Vet Sci
. 2023 Apr;
10(4).
PMID: 37104412
is one of the major pathogens of bovine respiratory disease (BRD), which can develop drug resistance to many of the commonly used antibiotics. Our earlier research group found that with...
5.
Wang X, Zeng Y, Chen G, Zhang Y, Li X, Hao X, et al.
Oncotarget
. 2016 Jul;
7(31):48953-48962.
PMID: 27418146
Network analysis has been widely used in studying Alzheimer's disease (AD). However, how the white matter network changes in cognitive impaired patients with subjective cognitive decline (SCD) (a symptom emerging...
6.
Li X, Tang Z, Sun Y, Tian J, Liu Z, Han Y
Oncotarget
. 2016 Jul;
7(34):54405-54414.
PMID: 27384675
Subjective cognitive decline (SCD) may be an at-risk stage of Alzheimer's disease (AD) occurring prior to amnestic mild cognitive impairment (aMCI). To examine white matter (WM) defects in SCD, diffusion...
7.
Chen G, Sheng C, Li Y, Yu Y, Wang X, Sun Y, et al.
BMC Neurol
. 2016 May;
16:64.
PMID: 27176479
Background: The ε4 allele of the Apolipoprotein E gene (APOE-ε4) is a potent genetic risk factor for sporadic Alzheimer's disease (AD). Amnestic mild cognitive impairment (aMCI) is an intermediate state...